3-hydroxy-O-phosphono-L-tyrosine
3-hydroxy-O-phosphono-L-tyrosine Uses, Dosage, Side Effects, Food Interaction and all others data.
3-hydroxy-O-phosphono-L-tyrosine is under investigation in clinical trial NCT04750226 (Study to Assess Adverse Events and Change in Disease Activity of 24-hour Continuous Subcutaneous Infusion of ABBV-951 in Adult Participants With Advanced Parkinson's Disease).
| Trade Name | 3-hydroxy-O-phosphono-L-tyrosine |
| Generic | Foslevodopa |
| Foslevodopa Other Names | 3-hydroxy-O-phosphono-L-tyrosine, Foslevodopa, Levodopa-4'-monophosphate |
| Type | |
| Formula | C9H12NO7P |
| Weight | Average: 277.169 Monoisotopic: 277.035138728 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here 3-hydroxy-O-phosphono-L-tyrosine
